BTIG Maintains Buy on Caris Life Sciences, Raises Price Target to $38
BTIG analyst Mark Massaro maintains Caris Life Sciences (NASDAQ:CAI) with a Buy and raises the price target from $33 to $38.
Equity
Caris Life Sciences, Inc. (CAI) Stock — Today's Move
$36.23
+$2.56 today
CAI is up 7.60% today. Volume is 2.00M vs a 30-day average of 4.36M (0.46x).
Day High
$36.25
Day Low
$33.50
Open
$33.52
Prev Close
$33.67
Volume
2.00M
Avg Vol (30d)
4.36M
52-Wk High
$36.25
52-Wk Low
$14.19
Sector
—
Today's Move
+7.60%
Next Earnings
Wed, Nov 4
Caris Life Sciences, Inc. is scheduled to report earnings Wed, Nov 4, 2026. Analysts expect EPS of $0.03 on revenue of about $257.92M. Stocks often move sharply on earnings day.
52-wk low $14.1952-wk high $36.25
CAI is 100% of the way from its 52-week low to its high.
Indicators:
Close price · volume bars (dashed line = average volume) · news that day (2M–1Y) — hover or tap the chart. Indicators are for education, not trading advice.
Why is CAI moving today?
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the launch of the second commercial in a series promoting Caris Detect™, Caris' multi-cancer early d…
Canaccord Genuity Maintains Hold on Caris Life Sciences, Raises Price Target to $30
Canaccord Genuity analyst Kyle Mikson maintains Caris Life Sciences (NASDAQ:CAI) with a Hold and raises the price target from $22 to $30.
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced it will report third quarter 2026 financial results on Wednesday, November 4, 2026.
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced that researchers from Caris and the Caris Precision Oncology Alliance® (Caris POA) will present eigh…
Related Movers
FFIV
▼ -20.55%
F5, Inc.
F5 (FFIV) Stock Could Be 14% Overvalued Despite Fresh AI Infrastructure News
$364.94
-$94.42
SLS
▼ -17.26%
SELLAS Life Sciences Group, Inc
SELLAS Life Sciences Stock Stumbles: What's Going On?
$10.07
-$2.10
ENPH
▼ -16.26%
Enphase Energy, Inc.
Susquehanna Maintains Neutral on Enphase Energy, Lowers Price Target to $26
$24.92
-$4.84
LSTR
▼ -16.15%
Landstar System, Inc.
Why Landstar System Stock Crashed After Earnings
$141.52
-$27.27
FAQ — CAI
Why is CAI moving today?
CAI is up 7.60% in the current session. Scroll to the news section below to see the most recent headlines and catalysts driving the move.
Is Caris Life Sciences, Inc. a good stock to buy today?
WeeklyTrader.io does not provide financial advice. Always verify catalysts, assess risk, and conduct your own research before making any investment decision.
What is CAI's average volume?
Average volume for CAI is approximately 4.36M shares per day based on the trailing 30 sessions.